Stocktoria
Bangkok Dusit Medical Services Public Company Limited BDMS.BK
Bangkok Dusit Medical Services Public Company Limited (BDMS.BK) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 3.89% (safety: stretched). FY2025 revenue was $111.5B at a 14.2% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 36 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | -0.003 |
| Retained earnings / assets | 0.38 |
| EBIT / assets | 0.128 |
| Equity / liabilities | 2.208 |
FAQ
Is BDMS.BK financially healthy?
Bangkok Dusit Medical Services Public Company Limited's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does BDMS.BK pay a dividend, and is it safe?
Yes. Bangkok Dusit Medical Services Public Company Limited pays a dividend yielding about 3.89% with a 75.2% payout ratio, rated “stretched” for safety.
How profitable is BDMS.BK?
In FY2025, Bangkok Dusit Medical Services Public Company Limited had a net margin of 14.2% and a return on equity of 15.0%.
Source: company filings via Yahoo Finance · TH · as of 2025-12-31. Figures in THB; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.